David Laharie

Bordeaux, 33000, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 224 publications

Methotrexate for inflammatory bowel disease: the MICI-METHO multicenter retrospective cohort study.

Methotrexate for inflammatory bowel disease: the MICI-METHO multicenter retrospective cohort study.

Journal: Journal of Crohn's & colitis
Published: July 22, 2026

Mirikizumab is associated with rapid and sustained improvements in novel measures of bowel urgency in moderately-to-severely active ulcerative colitis: 28-week results from the LUCENT-URGE trial.

Mirikizumab is associated with rapid and sustained improvements in novel measures of bowel urgency in moderately-to-severely active ulcerative colitis: 28-week results from the LUCENT-URGE trial.

Journal: Journal of Crohn's & colitis
Published: May 11, 2026

Association of bowel urgency, disease activity and disability in patients with inflammatory bowel disease: A cross-sectional study from the GETAID.

Association of bowel urgency, disease activity and disability in patients with inflammatory bowel disease: A cross-sectional study from the GETAID.

Journal: Clinics and research in hepatology and gastroenterology
Published: May 08, 2026

Ustekinumab for fistulising perianal Crohn's disease: a randomised placebo-controlled trial from the GETAID.

Ustekinumab for fistulising perianal Crohn's disease: a randomised placebo-controlled trial from the GETAID.

Journal: Gut
Published: April 16, 2026

One-Year Effectiveness of Upadacitinib in Perianal Crohn's Disease: A Real-World GETAID Study.

One-Year Effectiveness of Upadacitinib in Perianal Crohn's Disease: A Real-World GETAID Study.

Journal: Alimentary pharmacology & therapeutics
Published: February 17, 2026

Association between physical activity with disease activity and functional disability in patients with inflammatory bowel disease.

Association between physical activity with disease activity and functional disability in patients with inflammatory bowel disease.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Published: November 30, 2025

Diagnosis and management of patients with Crohn's disease. Position paper from the GETAID.

Diagnosis and management of patients with Crohn's disease. Position paper from the GETAID.

Journal: Clinics and research in hepatology and gastroenterology
Published: October 27, 2025

Update on IBD management: What's new in acute severe UC? - Modern management of perianal disease.

Update on IBD management: What's new in acute severe UC? - Modern management of perianal disease.

Journal: Clinics and research in hepatology and gastroenterology
Published: October 27, 2025

Patterns of conventional therapy use and advanced therapy initiation drivers in inflammatory bowel disease.

Patterns of conventional therapy use and advanced therapy initiation drivers in inflammatory bowel disease.

Journal: Therapeutic advances in gastroenterology
Published: October 24, 2025

IBD in transition, progresses and challenges.

IBD in transition, progresses and challenges.

Journal: Clinics and research in hepatology and gastroenterology
Published: October 22, 2025

Efficacy and Safety of Second-Line Advanced Therapy After Vedolizumab in Ulcerative Colitis: A Multicenter Cohort Study From the GETAID.

Efficacy and Safety of Second-Line Advanced Therapy After Vedolizumab in Ulcerative Colitis: A Multicenter Cohort Study From the GETAID.

Journal: United European gastroenterology journal
Published: October 19, 2025

Efficacy and Safety of Second-Line Advanced Therapy After Vedolizumab in Ulcerative Colitis: A Multicenter Cohort Study From the GETAID.

Efficacy and Safety of Second-Line Advanced Therapy After Vedolizumab in Ulcerative Colitis: A Multicenter Cohort Study From the GETAID.

Journal: United European gastroenterology journal
Published: October 19, 2025
Showing 1-12 of 224

Last Updated: 09/26/2026